Respiration; international review of thoracic diseases · 2025
Diagnosis of Peripheral Pulmonary Lesions Using Forceps and 1.1- or 1.7-mm Cryoprobes: A Randomised Trial.
СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Steinack Carolin, Rüschoff Jan Hendrik, Roeder Maurice, Vesenbeckh Silvan Manuel, Ulrich Silvia, Haberecker Martina, Nowack Miriam, Kohler Malcolm, Franzen Daniel P, Gaisl Thomas
Аннотация
INTRODUCTION: Lung cancer screening has increased the detection of peripheral pulmonary lesions (PPLs). Accurate diagnosis for therapy and prognosis is crucial but challenging. Our study compares the safety and efficacy of transbronchial cryobiopsy with two probe diameters and forceps biopsy.
METHODS: This single-centre, investigator-initiated, open-label, randomised trial included patients with PPLs who required flexible bronchoscopy with radial endobronchial ultrasound-guided biopsy for histopathological diagnosis. Patients received a forceps biopsy and were randomly assigned to a cryobiopsy with a 1.1-mm (freezing time 7-10 s) or a 1.7-mm cryoprobe (freezing time 4-6 s), respectively. The primary outcome was the diagnostic yield; secondary outcomes included total biopsy size, the proportion of malignant tissue, artefact-free alveolar space percentage, molecular pathology of the specimen, and safety.
RESULTS: Fifty-four patients (66.52 ± 9.81 years; 48.1% male) with a median nodule size of 24 mm (interquartile range 19-30) were included. The overall diagnostic yield was similar in the 1.1-mm and 1.7-mm groups (75.9% vs. 88.0%, p = 0.261), and the specimens obtained with the two different cryoprobes were equal in size, quality, and information about molecular pathology. There was no difference in procedural-related bleeding between the groups (p = 0.847). Compared to forceps biopsies, cryobiopsies had a superior overall diagnostic yield (75.9% vs. 48.1%, p = 0.001) and were better suited for further molecular analysis (p = 0.001).
CONCLUSION: The 1.1-mm and 1.7-mm cryoprobes displayed comparable diagnostic yield, ability to provide molecular pathology information, and safety. Forceps biopsy was inferior to cryobiopsy in all aspects except safety.
METHODS: This single-centre, investigator-initiated, open-label, randomised trial included patients with PPLs who required flexible bronchoscopy with radial endobronchial ultrasound-guided biopsy for histopathological diagnosis. Patients received a forceps biopsy and were randomly assigned to a cryobiopsy with a 1.1-mm (freezing time 7-10 s) or a 1.7-mm cryoprobe (freezing time 4-6 s), respectively. The primary outcome was the diagnostic yield; secondary outcomes included total biopsy size, the proportion of malignant tissue, artefact-free alveolar space percentage, molecular pathology of the specimen, and safety.
RESULTS: Fifty-four patients (66.52 ± 9.81 years; 48.1% male) with a median nodule size of 24 mm (interquartile range 19-30) were included. The overall diagnostic yield was similar in the 1.1-mm and 1.7-mm groups (75.9% vs. 88.0%, p = 0.261), and the specimens obtained with the two different cryoprobes were equal in size, quality, and information about molecular pathology. There was no difference in procedural-related bleeding between the groups (p = 0.847). Compared to forceps biopsies, cryobiopsies had a superior overall diagnostic yield (75.9% vs. 48.1%, p = 0.001) and were better suited for further molecular analysis (p = 0.001).
CONCLUSION: The 1.1-mm and 1.7-mm cryoprobes displayed comparable diagnostic yield, ability to provide molecular pathology information, and safety. Forceps biopsy was inferior to cryobiopsy in all aspects except safety.